What is the choice of treatment for Hafnia alvei bacteremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Treatment of Hafnia alvei Bacteremia

The choice of treatment for Hafnia alvei bacteremia depends on various factors, including the severity of the infection, the patient's underlying health conditions, and the susceptibility of the bacteria to antibiotics.

  • Antibiotic treatment options include:
    • Cefepime, as used in patients with Hafnia alvei-induced urosepsis 1, 2
    • Netilmicin and Imipenem, which were successful in treating two patients with nosocomial infections 3
    • Ciprofloxacin, which was used to treat a patient with Hafnia alvei pyelonephritis and urosepsis 2
  • The susceptibility of Hafnia alvei to various antibiotics has been reported in several studies, including:
    • 100% susceptibility to netilmicin, ciprofloxacin, and imipenem 4
    • 92% susceptibility to piperacillin 4
    • 90% susceptibility to co-trimoxazole 4
    • 88% susceptibility to ceftriaxone and ceftazidime 4
  • It is essential to note that Hafnia alvei can produce inducible Bush group 1 beta-lactamase, which may contribute to antibiotic resistance 1
  • In some cases, the source of bacteremia may be associated with central venous catheters, and removal of the catheter may be necessary as part of the treatment 5

References

Research

Hafnia alvei Urosepsis in a Kidney Transplant Patient.

Case reports in transplantation, 2015

Research

[Typical nosocomial infection with an unusual cause: Hafnia alvei. Report of 2 cases and literature review].

Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1990

Research

Clinical significance of extraintestinal Hafnia alvei isolates from 61 patients and review of the literature.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996

Research

[Report of four clinical cases of Hafnia alvei bacteremia in a pediatric cardiac surgery unit].

Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.